FDA Gives Green Light for Groundbreaking Clinical Trial for Autism

[Jeannine]

FDA Gives Green Light for Groundbreaking Clinical Trial for Autism
By Sutter Neuroscience Institute

Published: Tuesday, Aug. 21, 2012 - 8:11 am
SACRAMENTO, Calif., Aug. 21, 2012 -- /PRNewswire/ -- Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world's largest stem cell bank, are launching the first FDA-approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.

To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/57707-cor...s-child-autism